A testosterone replacement therapy (TRT) evaluation usually starts with the questions you'd expect: energy, libido, mood, muscle mass, and a lab draw to confirm low testosterone. Somewhere in that conversation, though, a licensed clinician is also likely to ask how you sleep, whether you snore, and whether anyone has noticed you gasp or stop breathing at night. That's not a throwaway question. It's tied to a specific safety signal that testosterone product labeling addresses directly: testosterone therapy can worsen obstructive sleep apnea in some people.
This is patient education, not medical advice. Only an independent licensed medical professional can determine whether testosterone therapy, and what monitoring around it, is appropriate for you.
Why sleep apnea comes up during a TRT evaluation
Sleep apnea isn't an afterthought in a TRT evaluation; it's built into how testosterone therapy is prescribed responsibly. Testosterone product labeling includes a warning that testosterone therapy may worsen obstructive sleep apnea in some people, which is one reason a thorough health history, not just a testosterone level on a lab report, is part of a proper evaluation before treatment starts.
There's a second reason it matters, separate from testosterone entirely: untreated obstructive sleep apnea carries its own health risks, including strain on the cardiovascular system, that a clinician needs to know about regardless of whether TRT is ever prescribed. A TRT evaluation is often the first time some people are asked directly and specifically about their sleep, which means it can surface an unrelated but important health issue.
You can read more about how a TRT evaluation is structured more broadly in our explainer on what testosterone replacement therapy is and who it's generally considered for.
What obstructive sleep apnea is, and why its symptoms overlap with low testosterone
Obstructive sleep apnea (OSA) happens when the airway repeatedly narrows or collapses during sleep, briefly interrupting breathing many times a night, often without the person waking up enough to remember it. Common features include loud, frequent snoring, gasping or choking sounds, witnessed pauses in breathing reported by a partner, morning headaches, and pronounced daytime sleepiness or difficulty concentrating.
Look closely at that list and the overlap with low-testosterone complaints is hard to miss. Fatigue, low energy, low libido, trouble concentrating, and mood changes are among the symptoms commonly associated with low testosterone, and they're also hallmark daytime effects of poor-quality, fragmented sleep. Someone with undiagnosed sleep apnea can look, on symptoms alone, a lot like someone with low testosterone, and it's entirely possible to have both at the same time. Obesity is also a shared risk factor for each condition, which adds another layer to why they're often discussed together rather than treated as unrelated issues.
That overlap is exactly why symptoms alone were never meant to drive a testosterone diagnosis or a treatment decision. A clinician working through a low-testosterone complaint is also, implicitly, ruling other explanations in or out, and sleep apnea is one of the more consequential ones to catch.
What the evidence and product labeling say about testosterone and sleep apnea
Testosterone product labeling in the United States describes a possible worsening of obstructive sleep apnea associated with testosterone use in some patients, particularly those who already have risk factors for it. Researchers haven't fully settled every detail of why this happens in some people and not others, but the labeling itself reflects an observed clinical signal, not a hypothetical concern, which is why it's treated as load-bearing information rather than fine print.
What this warning does, and doesn't, mean
It doesn't mean testosterone therapy causes sleep apnea in everyone, or that a diagnosis of sleep apnea automatically disqualifies someone from treatment. It means the risk is real enough, in some people, that it belongs in the conversation before treatment starts and in the monitoring plan afterward.
This is one of several cardiovascular- and safety-adjacent considerations that come up in a TRT evaluation alongside sleep apnea; our explainer on testosterone therapy and cardiovascular risk covers the related, and sometimes overlapping, heart-health questions clinicians weigh at the same time.
Who needs extra caution, and why screening matters
People with diagnosed but untreated or poorly controlled obstructive sleep apnea, particularly more severe cases, are the group clinicians approach with the most caution before starting testosterone therapy. That caution isn't a blanket refusal; it's a reason to slow down, evaluate more closely, and sometimes address the sleep apnea, or at least understand its severity, before or alongside starting TRT.
People who haven't been formally diagnosed but who have risk factors and symptoms suggestive of sleep apnea are also worth flagging. That includes loud or frequent snoring, witnessed breathing pauses, excessive daytime sleepiness, morning headaches, a thicker neck circumference, and uncontrolled high blood pressure, which sleep apnea can contribute to. None of these alone confirms sleep apnea, but together they're often enough for a clinician to recommend a formal sleep evaluation, such as a sleep study, before moving forward.
- Untreated, severe OSA generally calls for the most caution and closest evaluation.
- Diagnosed OSA that's being actively treated, for example with CPAP therapy, is a different starting point than untreated disease, and your clinician will factor in how well-controlled it is.
- Unevaluated symptoms, like loud snoring or witnessed breathing pauses without a diagnosis, are worth raising even if you've never been formally tested.
Monitoring for sleep apnea symptoms during treatment
Screening before treatment starts is only half of how this risk is managed responsibly; monitoring after treatment begins is the other half. In the same way clinicians typically track blood pressure and lab values during TRT, they also periodically check in on sleep quality, snoring, and daytime alertness as part of routine follow-up.
New or worsening symptoms after starting testosterone therapy, louder or more frequent snoring, a partner noticing breathing pauses that weren't there before, or a return of daytime sleepiness, are worth reporting promptly rather than waiting for a scheduled check-in. Depending on what's reported, a clinician might reassess your dose, refer you for a sleep evaluation, or adjust the broader treatment plan. This kind of ongoing feedback loop is part of why TRT is managed as a supervised, prescription-based treatment rather than something started once and left unmonitored.
Talking to your clinician about your risk
Because so much of this hinges on details a lab result can't capture, being specific with your clinician matters. A few things worth mentioning clearly during an evaluation: whether you or a partner has noticed snoring or breathing pauses, whether you wake up feeling unrested despite a full night's sleep, whether you've ever been evaluated for sleep apnea before, and whether you're currently using any sleep apnea treatment, such as CPAP.
Bringing this up doesn't mean treatment is off the table. It means your clinician can make a more accurate, individualized decision about whether TRT is appropriate, how it should be monitored, and whether a sleep evaluation should happen first. Starting an online evaluation does not guarantee a prescription; an independent licensed clinician reviews your health history and decides what's appropriate for you.
You can explore more of our clinician-reviewed testosterone therapy explainers for related safety topics, or read about our editorial standards on the About the Journal page.
The bottom line
Testosterone product labeling warns that testosterone therapy may worsen obstructive sleep apnea in some people, and because low-testosterone symptoms like fatigue overlap heavily with sleep apnea symptoms, a proper evaluation screens for both before treatment starts. Sleep apnea doesn't automatically disqualify someone from TRT, but untreated, severe cases call for extra caution, and ongoing monitoring for sleep-related symptoms is a standard part of responsible, clinician-directed care.
Important Safety Information
Indication. Testosterone replacement therapy is FDA-approved to treat adult men with low testosterone caused by specific medical conditions that affect the testicles, pituitary gland, or brain and reduce the body's natural testosterone production; it is not FDA-approved simply for a decline in testosterone associated with aging alone.
Common side effects. Acne or oily skin, injection-site or application-site reactions, fluid retention, increased red blood cell count, and breast tenderness or enlargement have been reported.
Warnings. Testosterone product labeling describes a possible increased risk of heart attack and stroke, and states that testosterone therapy may worsen obstructive sleep apnea in some people. Testosterone should not be used in men with breast cancer or known or suspected prostate cancer, and it may worsen symptoms of benign prostatic hyperplasia and increase red blood cell counts requiring monitoring. Topical testosterone products carry warnings about the potential for secondary exposure to testosterone in children and women through skin contact.
Talk to your doctor. This information is educational and is not a substitute for medical advice. Only a licensed medical professional can determine whether a treatment is right for you. Talk to your doctor about the benefits and risks, and report any side effects.
Frequently asked questions
Can testosterone therapy actually make sleep apnea worse?
Yes, this is a recognized warning in testosterone product labeling. Testosterone therapy has been associated with worsening obstructive sleep apnea in some people, though not everyone who starts treatment is affected. It's one of the reasons clinicians ask about sleep-related symptoms before prescribing and monitor for changes afterward.
Does having sleep apnea automatically rule out testosterone therapy?
No. Sleep apnea doesn't automatically disqualify someone from TRT, but untreated, severe obstructive sleep apnea is a condition clinicians weigh carefully, and it's one reason a full evaluation matters more than a symptom checklist. If you have diagnosed or suspected sleep apnea, your clinician will factor that into whether and how to proceed.
What are the warning signs of sleep apnea I should mention to a clinician?
Loud, frequent snoring, gasping or choking during sleep, witnessed pauses in breathing, morning headaches, and excessive daytime sleepiness are commonly associated with obstructive sleep apnea. Because several of these, like fatigue and low energy, also overlap with symptoms attributed to low testosterone, mentioning them clearly helps a clinician sort out what's actually going on.
Will I be screened for sleep apnea before starting TRT?
As part of a thorough evaluation, a clinician typically asks about sleep quality, snoring, and daytime fatigue as part of your broader health history. Depending on your answers and risk factors, they may recommend a formal sleep apnea evaluation, such as a sleep study, before or alongside starting testosterone therapy.
If I develop sleep apnea symptoms after starting testosterone therapy, what should I do?
Contact your prescribing clinician. New or worsening snoring, witnessed breathing pauses, or increased daytime sleepiness after starting testosterone therapy are worth reporting promptly, since your clinician may want to reassess your dose, evaluate for sleep apnea, or adjust your treatment plan.
